A phase-II study of combination of pegylated interferon alfa-2a and capecitabine in locally advanced or metastatic renal cell cancer

被引：0
|
作者：
Kaisa Leea Sunela
Sanna Koskinen
Pirkko-Liisa Kellokumpu-Lehtinen
机构：
[1] Tampere University Hospital,Department of Oncology
[2] University of Tampere Medical School,Department of Oncology
[3] University of Tampere,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2010年 / 66卷
关键词：
Renal cell carcinoma; Immunotherapy; Interferon; Pegylated; Chemotherapy; Capecitabine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：59 / 67
页数：8
相关论文
共 50 条
  • [1] A phase-II study of combination of pegylated interferon alfa-2a and capecitabine in locally advanced or metastatic renal cell cancer
    Sunela, Kaisa Leea
    Koskinen, Sanna
    Kellokumpu-Lehtinen, Pirkko-Liisa
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (01) : 59 - 67
  • [2] Combination therapy with capecitabine and interferon alfa-2A in patients with advanced renal cell carcinoma: a phase II study
    Padrik, P
    Leppik, K
    Arak, A
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2004, 22 (05) : 387 - 392
  • [3] A phase-II study of pegylated interferon alfa-2b for patients with metastatic renal cell carcinoma and removal of the primary tumor
    Bex, A
    Mallo, H
    Kerst, M
    Haanen, J
    Horenblas, S
    de Gast, GC
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (07) : 713 - 719
  • [4] A phase-II study of pegylated interferon alfa-2b for patients with metastatic renal cell carcinoma and removal of the primary tumor
    Axel Bex
    Henk Mallo
    Martijn Kerst
    John Haanen
    Simon Horenblas
    Gijsbert C. de Gast
    Cancer Immunology, Immunotherapy, 2005, 54 : 713 - 719
  • [5] A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer
    Hong Suk Song
    Young Rok Do
    Heung Moon Chang
    Min Hee Ryu
    Kyung Hee Lee
    Yeul Hong Kim
    Dae Sik Hong
    Jae Yong Cho
    Kyoung Eun Lee
    Si Young Kim
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 763 - 768
  • [6] A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer
    Song, Hong Suk
    Do, Young Rok
    Chang, Heung Moon
    Ryu, Min Hee
    Lee, Kyung Hee
    Kim, Yeul Hong
    Hong, Dae Sik
    Cho, Jae Yong
    Lee, Kyoung Eun
    Kim, Si Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (05) : 763 - 768
  • [7] A Multicenter Phase II Study of Gemcitabine, Capecitabine, and Bevacizumbab for Locally Advanced or Metastatic Biliary Tract Cancer
    Iyer, Renuka V.
    Pokuri, Venkata K.
    Groman, Adrienne
    Ma, Wen W.
    Malhotra, Usha
    Iancu, Dan M.
    Grande, Catherine
    Saab, Tanios B.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (07): : 649 - 655
  • [8] RECOMBINANT INTERFERON ALFA-2A WITH OR WITHOUT VINBLASTINE IN METASTATIC RENAL-CELL CARCINOMA - RESULTS OF A EUROPEAN MULTICENTER PHASE-III STUDY
    FOSSA, SD
    MARTINELLI, G
    OTTO, U
    SCHNEIDER, G
    WANDER, H
    OBERLING, F
    BAUER, HW
    ACHTNICHT, U
    HOLDENER, EE
    ANNALS OF ONCOLOGY, 1992, 3 (04) : 301 - 305
  • [9] Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer
    Vahdat, Linda T.
    Layman, Rachel
    Yardley, Denise A.
    Gradishar, William
    Salkeni, Mohamad A.
    Joy, Anil Abraham
    Garcia, Agustin A.
    Ward, Patrick
    Khatcheressian, James
    Sparano, Joseph
    Rodriguez, Gladys
    Tang, Shande
    Gao, Ling
    Dalal, Rita P.
    Kauh, John
    Miller, Kathy
    ONCOLOGIST, 2017, 22 (03) : 245 - 254
  • [10] M-VAC COMBINATION IN LOCALLY ADVANCED, LOCALLY RECURRENT OR METASTATIC BREAST-CARCINOMA - A PHASE-II STUDY
    BISAGNI, G
    COCCONI, G
    CECI, G
    DELISI, V
    DIBLASIO, B
    LOTTICI, R
    PASSALACQUA, R
    FINARDI, C
    ANNALS OF ONCOLOGY, 1994, 5 (01) : 93 - 94
12345